arrow
Back
D

Dean Bottino

Takeda Development Center Americas

16H-index
80Paper Count
979Citation Count
Published Papers 22
Publication Date
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs
err2025-06-05
err0
PREAI
errWei Gao; Jiang Liu; Cynthia J. Musante; Hao Zhu; Matthew Thompson; Mirat Shah; Yanguang Cao; Vijay Ivaturi; Mark R. Conaway; Dean Bottino; Donghua Yin; Dorothee Semiond; Aram Oganesian; Mark J. Ratain; Chunze Li; Li Zhu; Ying C. Ou; Xiling Jiang; Jonathan Vallejo; Rajanikanth Madabushi; Qi Liu; Marc Theoret; Atiqur Rahman; Brian Booth; Olanrewaju Okusanya; Bernadette E. Johnson-Williams; Stacy S. Shord
errShare
errSave
Modeling serum M-protein response for early detection of biochemical relapse in myeloma patients treated with bortezomib, lenalidomide and dexamethasone
err2024-09-17
err0
errOAAI
errOtani, Yuki; Zhao, Yunqi; Wang, Guanyu; Labotka, Richard; Rogge, Mark; Gupta, Neeraj; Vakilynejad, Majid; Bottino, Dean; Tanigawara, Yusuke
errShare
errSave
Impact of drug combination schedules on the evolution of tumor resistance
err2024-03-22
err0
PREAI
errStoddard, Madison; Chen, Andrew; Yuan, Lin; Van Egeren, Debra; Bottino, Dean; Chakravarty, Arijit
errShare
errSave
Understanding three-drug combinations: optimizing scheduling while avoiding toxicity
err2024-03-22
err0
PREAI
errStoddard, Madison; Yuan, Lin; Van Egeren, Debra; Chen, Andrew; Bottino, Dean; Chakravarty, Arijit
errShare
errSave
Model-derived progression-free survival (mPFS): A better metric for patient-derived xenograft studies
err2024-03-22
err0
PREAI
errChen, Andrew; Stoddard, Madison; Yuan, Lin; Van Egeren, Debra; Chakravarty, Arijit; Bottino, Dean
errShare
errSave
Towards better prediction of treatment resistance: Directly modeling progression from multiple lesions
err2024-03-22
err0
PREAI
errProtich, Samuel; Stoddard, Madison; Yuan, Lin; White, Douglas; Bottino, Dean; Chakravarty, Arijit
errShare
errSave
Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy
err2023-04-06
err3
errOAAI
errStoddard, Madison; Yuan, Lin; Sarkar, Sharanya; Mangalaganesh, Shruthi; Nolan, Ryan P.; Bottino, Dean; Hather, Greg; Hochberg, Natasha S.; White, Laura F.; Chakravarty, Arijit
errShare
errSave
From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy
err2022-11-10
err12
errOAAI
errLemaire, Vincent; Bassen, David; Reed, Mike; Song, Roy; Khalili, Samira; Lien, Yi Ting Kayla; Huang, Lu; Singh, Aman P.; Stamatelos, Spyros; Bottino, Dean; Hua, Fei
errShare
errSave
CONDITIONAL BISPECIFIC T CELL ENGAGER DESIGN AND DOSING OPTIMIZATION VIA MECHANISTIC MODELING
err2022-11-07
err0
errOAAI
errWu, Jess; Vilkhovoy, Michael; Shum, Sara; Chouitar, Johara; Leroy, Patrick; Fridman, Leticia; Kwok, Eilene; Wu, Glendon; Ecsedi, Matyas; Banerjee, Antara; Bottino, Dean
errShare
errSave
Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development Paradigm
err2020-08-14
err54
errOAAI
errChelliah, Vijayalakshmi; Lazarou, Georgia; Bhatnagar, Sumit; Gibbs, John P.; Nijsen, Marjoleen; Ray, Avijit; Stoll, Brian; Thompson, R. Adam; Gulati, Abhishek; Soukharev, Serguei; Yamada, Akihiro; Weddell, Jared; Sayama, Hiroyuki; Oishi, Masayo; Wittemer-Rump, Sabine; Patel, Chirag; Niederalt, Christoph; Burghaus, Rolf; Scheerans, Christian; Lippert, Joerg; Kabilan, Senthil; Kareva, Irina; Belousova, Natalya; Rolfe, Alex; Zutshi, Anup; Chenel, Marylore; Venezia, Filippo; Fouliard, Sylvain; Oberwittler, Heike; Scholer-Dahirel, Alix; Lelievre, Helene; Bottino, Dean; Collins, Sabrina C.; Nguyen, Hoa Q.; Wang, Haiqing; Yoneyama, Tomoki; Zhu, Andy Z. X.; van der Graaf, Piet H.; Kierzek, Andrzej M.
errShare
errSave
Quantitative Translation in Immuno-Oncology Research and Development
err2020-07-09
err0
errOAAI
errBottino, Dean; Liu, Rachael; Bazzazi, Hojjat; Venkatakrishnan, Karthik
errShare
errSave
Evaluation of large-scale quantitative systems pharmacology model predictions of in vitro cancer cell line sensitivity to TAK-659, an investigational oral spleen tyrosine kinase (SYK) inhibitor
err2019-12-01
err0
PREAI
errAbbasi, Taher; Vali, Shireen; Williams, Miguel; Sappal, Jessica; Li, Cong; Shin, Hyunjin; Gregory, Rick; Wu, Yujun; Wang, Shining; Stumpo, Kate; Bottino, Dean
errShare
errSave
Transforming Translation Through Quantitative Pharmacology for High-Impact Decision Making in Drug Discovery and Development
err2019-11-10
err9
PREAI
errGupta, Neeraj; Bottino, Dean; Simonsson, Ulrika S. H.; Musante, Cynthia J.; Bueters, Tjerk; Rieger, Theodore R.; Macha, Sreeraj; Chenel, Marylore; Fancourt, Craig; Kanodia, Jitendra; Nayak, Satyaprakash
errShare
errSave
Directional inconsistency between Response Evaluation Criteria in Solid Tumors (RECIST) time to progression and response speed and depth
err2019-03-01
err11
PREAI
errJohnson, Kaitlyn; Gomez, Axel; Burton, Jackson; White, Douglas; Chakravarty, Arijit; Schmid, Annette; Bottino, Dean
errShare
errSave
A model-based approach toward clinical pipeline optimization
err2015-08-01
err1
PREAI
errBurton, Jackson; Antebi, William; Zopf, Christopher J.; Bottino, Dean; Teng, Shu-Wen; Nolan, Ryan; Chakravarty, Arijit
errShare
errSave
Anticipating the maximum tolerated dose for combinations based on early toxicity signals
err2014-10-01
err0
PREAI
errKadakia, Ekta; Zopf, Christopher J.; Patel, Mayankbhai; Bottino, Dean; Hather, Greg; Shyu, Wen Chyi; Chakravarty, Arijit
errShare
errSave